Page 1

RESEARCH REPORT 2017-2023 Alzheimer’s disease Therapeutics and Diagnostics Market Segmented by Therapeutics, by Diagnostics, and by end user analysis, size, share, growth, Trends and forecasts 2016-2021


Global Alzheimer’s disease Therapeutics and Diagnostics

Alzheimer’s Disease Therapeutics and Diagnostics Market Study :

Alzheimer’s disease (AD) is the maximum everyday reason of modern dementia in the elderly population. There has been an exponential boom within the frequency of Alzheimer’s ailment instances globally, stressing the want to increase an useful treatment to cure it.

Presently, very few therapeutic alternatives are gift within the market and none of them offer a complete treatment for this condition. Hence, access into the market would offer moneymaking increase possibilities to the enterprise gamers.

The boom of the Global Alzheimer’s Disease Therapeutics and Diagnostics Market is mainly driven by way of factors consisting of growing vintage age population, growing R&D funding, excessive frequency of Alzheimer’s and neurodegenerative diseases, and advanced existence expectancy of the general population. However, elements such as the astronomical value of remedy and lack of proper repayment guidelines are preventing the increase of the marketplace.

Alzheimer’s Disease Therapeutics and Diagnostics Market Growth, and Value:

According to the Research Report, the Global Alzheimer’s Disease Therapeutics and Diagnostics Market is posted by the Market Data Forecast. The marketplace become really worth USD nine.92 billion in 2016 and estimated to be growing at a CAGR of 4.62%, to reach USD 12.43 billion from the forecast duration 2016 to 2021.

Market Segmentation Analysis:

The Global Alzheimer’s Disease Therapeutics and Diagnostics marketplace is segmented primarily based on Therapeutics and Diagnostics. The market for Alzheimer’s Disease Therapeutics and Diagnostics, on the premise of Therapeutics, is segmented into Marketed Drugs and Pipeline Drugs. Marketed Drugs are in addition segmented into NMDA Receptor Antagonists and Cholinesterase Inhibitors. Marketed Drugs lead the global market on the idea of Therapeutics due to a big person base. On the idea of Diagnostics, the global Alzheimer’s Disease Therapeutics and Diagnostics marketplace are segmented into Computed tomography scan, Electroencephalography, Lumbar puncture test, Magnetic resonance imaging, Positron emission tomography, and Others. Under this phase, Computed tomography experiment section leads the worldwide Alzheimer’s Disease Therapeutics and Diagnostics marketplace. The absence of opportunity imaging tool for brain and neurological diagnostics is one of the critical reasons for its huge proportion.

+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com


Global Alzheimer’s disease Therapeutics and Diagnostics

Market Regional Analysis: The market has additionally been geographically segmented into North America, Europe, AsiaPacific, Latin America and Middle-East & Africa. North America is anticipated to be the most important marketplace for Alzheimer’s ailment Therapeutics and Diagnostics because of the growing prevalence of Alzheimer’s sickness and full-size technological tendencies inside the place. With the upward thrust in growing older populace inside the growing location of Asia Pacific, this marketplace is projected to develop at the highest CAGR all through the forecast duration. Alzheimer’s Disease Therapeutics and Diagnostics Market Key players: Leading organizations have implemented techniques which includes mergers & acquisitions, collaborations, and joint ventures to advantage a sturdy foothold inside the marketplace. The principal agencies dominating the worldwide Alzheimer’s Disease Therapeutics and Diagnostics market are Abbvie Inc., Pfizer Inc., AC Immune SA, Eisai Co Ltd., Allergan PLC, Novartis AG, Amarantus Bioscience Holdings, H. Lundbeck A/S, Anavex LifeSciences, Avid Radiopharmaceuticals, Forest Laboratories Inc., Axon Neuroscience, Daiichi Sankyo Co, TauRx Therapeutics Ltd, Eli Lilly, F. Hoffmann La Roche AG, Johnson & Johnson, GE Healthcare, Janssen Pharmaceuticals and so on. Research Report Benefits:     

The assessment of the current marketplace in your product or offerings and the future implications of the marketplace Addresses the possibilities by using better understanding the marketplace through size estimates and growth charge analysis to forecast the marketplace for the future The results of political, economic, social, technological, legal and environmental elements at the enterprise is analyzed via PESTLE analysis to higher apprehend the components of strategic control required to comply with the exogenous and endogenous factors Strategic assessment of the important thing gamers to advantage insights in their performance allowing access to their product portfolio, financial overall performance and the strengths of their business strategic trends Comparative take a look at of the corporations throughout the industry measuring their performances based totally on marketplace share and latest activities so one can attain competitive intelligence Equip you with the facts offering with the investment opportunities within the industry

+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com


Global Alzheimer’s disease Therapeutics and Diagnostics

TABLE OF CONTENTS 1.Introduction 1.1 Market Definition 1.2 Study Deliverables 1.3 Base Currency, Base Year and Forecast Periods 1.4 General Study Assumptions 2. Research Methodology 2.1 Introduction 2.2 Research Phases 2.2.1 Secondary Research 2.2.2 Primary Research 2.2.3 Econometric Modelling 2.2.4 Expert Validation 2.3 Analysis Design 2.4 Study Timeline 3. Overview 3.1 Executive Summary 3.2 Key Inferences 3.3 Epidemology 4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC) 4.1 Market Drivers 4.2 Market Restraints 4.3 Key Challenges 4.4 Current Opportunities in the Market 5. Market Segmentation

+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com


Global Alzheimer’s disease Therapeutics and Diagnostics

5.1 Therapeutics 5.1.1 Introduction 5.1.2 Marketed Drugs 5.1.2.1 NMDA Receptor Antagonists 5.1.2.2 Cholinesterase Inhibitors 5.1.3 Pipeline Drugs 5.1.4 Y-o-Y Growth Analysis, By Therapeutics 5.1.5 Market Attractiveness Analysis, By Therapeutics 5.1.6 Market Share Analysis, By Therapeutics 5.2 Diagnostics 5.2.1 Introduction 5.2.2 Computed tomography scan 5.2.3 Electroencephalography 5.2.4 Lumbar puncture test 5.2.5 Magnetic resonance imaging 5.2.6 Positron emission tomography 5.2.7 Others 5.2.8 Y-o-Y Growth Analysis, By Diagnostics 5.2.9 Market Attractiveness Analysis, By Diagnostics 5.2.10 Market Share Analysis, By Diagnostics View Full Report @ https://www.marketdataforecast.com/market-reports/global-alzheimersdisease-therapeutics-and-diagnostics-market-2247/

6. Geographical Analysis 6.1 Introduction 6.1.1 Regional Trends

+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com


Global Alzheimer’s disease Therapeutics and Diagnostics

6.1.2 Impact Analysis 6.1.3 Y-o-Y Growth Analysis 6.1.3.1 By Geographical Area 6.1.3.2 By Therapeutics 6.1.3.3 By Diagnostics 6.1.4 Market Attractiveness Analysis 6.1.4.1 By Geographical Area 6.1.4.2 By Therapeutics 6.1.4.3 By Diagnostics 6.1.5 Market Share Analysis 6.1.5.1 By Geographical Area 6.1.5.2 By Therapeutics 6.1.5.3 By Diagnostics 6.2 North America 6.1.1 Introduction 6.1.2 United States 6.1.3 Canada 6.3 Europe 6.2.1 Introduction 6.2.2 U.K 6.2.3 Spain 6.2.4 Germany 6.2.5 Italy 6.2.6 France 6.4 Asia-Pacific

+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com


Global Alzheimer’s disease Therapeutics and Diagnostics

Get Free Sample Report @ https://www.marketdataforecast.com/market-reports/globalalzheimers-disease-therapeutics-and-diagnostics-market-2247/request-sample 6.3.1 Introduction 6.3.2 China 6.3.3 India 6.3.4 Japan 6.3.5 Australia 6.3.6 South Korea 6.5 Latin America 6.4.1 Introduction 6.4.2 Brazil 6.4.3 Argentina 6.4.4 Mexico 6.4.5 Rest of Latin America 6.6 Middle East & Africa 6.5.1 Introduction 6.5.2 Middle-East 6.5.3 Africa Buy now @ https://www.marketdataforecast.com/cart/buy-now/global-alzheimers-diseasetherapeutics-and-diagnostics-market-2247/

7.Strategic Analysis 7.1 PESTLE analysis 7.1.1 Political 7.1.2 Economic 7.1.3 Social

+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com


Global Alzheimer’s disease Therapeutics and Diagnostics

7.1.4 Technological 7.1.5 Legal 7.1.6 Environmental 7.2 Porter’s Five analysis 7.2.1 Bargaining Power of Suppliers 7.2.2 Bargaining Power of Consumers 7.2.3 Threat of New Entrants 7.2.4 Threat of Substitute Products and Services 7.2.5 Competitive Rivalry within the Industry 8.Market Leaders' Analysis 8.1 Abbvie Inc. 8.1.1 Overview 8.1.2 Product Analysis 8.1.3 Financial analysis 8.1.4 Recent Developments 8.1.5 SWOT analysis 8.1.6 Analyst View 8.2 Pfizer Inc. 8.3 AC Immune SA 8.4 Eisai Co Ltd. 8.5 Allergan PLC 8.6 Novartis AG 8.7 Amarantus Bioscience Holdings 8.8 H. Lundbeck A/S 8.9 Anavex LifeSciencescs

+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com


Global Alzheimer’s disease Therapeutics and Diagnostics

8.10 Avid Radiopharmaceuticals 8.11 Forest Laboratories Inc. 8.12 Axon Neuroscience 8.13 Daiichi Sankyo Co 8.14 TauRx Therapeutics Ltd 8.15 Eli Lilly 8.16 F. Hoffmann La Roche AG 8.17 Johnson & Johnson 8.18 GE Healthcare 8.19 Janssen Pharmaceuticals 9.Competitive Landscape 9.1 Market share analysis 9.2 Merger and Acquisition Analysis 9.3 Agreements, collaborations and Joint Ventures 9.4 New Product Launches 10.Market Outlook and Investment Opportunities Appendix a) List of Tables b) List of Figures

+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com


Global Alzheimer’s disease Therapeutics and Diagnostics

SCOPE OF THE REPORT 

Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped

Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail

Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics

Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis

Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development

A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment

Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies

An executive summary, abridging the entire report in such a way that decisionmaking personnel can rapidly become acquainted with background information, concise analysis and main conclusions

Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com


ABOUT US Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across various business domains and we cater to the needs of both individual and corporate clients. Our research services assist clients in key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality. CONTACT INFORMATION We always look forward to working with new clients, pushing our boundaries and extending our reach beyond global horizons. Get in touch with us for further queries. Website: www.marketdataforecast.com E-Mail: contact@marketdataforecast.com Phone: +1 888-702-9626 (U.S Toll free), +91 7680952236 (Indian Office).

FOR MORE INFORMATION

+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com

Alzheimer’s disease therapeutics and diagnostics market  

The market was worth USD 9.92 billion in 2016 and estimated to be growing at a CAGR of 4.62%, to reach USD 12.43 billion from the forecast p...

Alzheimer’s disease therapeutics and diagnostics market  

The market was worth USD 9.92 billion in 2016 and estimated to be growing at a CAGR of 4.62%, to reach USD 12.43 billion from the forecast p...

Advertisement